Illumina IncILMN

ILMN current price
$100.24-26.42%

Capital at risk.

1W
-4.07%
1M
-25.74%
3M
-23.33%
6M
-26.24%
1Y
-26.42%
MAX
-49.27%
About Illumina Inc
Ticker
info
ILMN
Trading on
info
NASDAQ
ISIN
info
US4523271090
Industry
info
Diagnostics & Research
Sector
info
Healthcare
CEO
info
Jacob Thaysen Ph.D.
Headquarters
info
5200 Illumina Way, San Diego, CA, United States, 92122
Employees
info
10,590
Website
info
illumina.com
Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
Metrics
BasicAdvanced
Market cap
info
$16.1B
P/E ratio
info
-
EPS
info
-$7.68
Dividend Yield
info
0.00%
Beta
info
1.13
Forward P/E ratio
info
22.73
EBIDTA
info
$730M
Ex dividend date
info
-
Price & volume
Market cap
info
$16.1B
Average daily volume
info
2.7M
90-day return
info
-23.33%
30-day return
info
-25.74%
7-day return
info
-4.07%
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
22.73
PEG ratio
info
0.62
Trailing P/E
info
0
Price to sales
info
3.68
Price to book
info
6.92
Earnings
EPS
info
-$7.68
EPS estimate (current quarter)
info
$0.92
EPS estimate (next quarter)
info
$1.00
EBITDA
info
$730M
Revenues (TTM)
info
$4.39B
Revenues per share (TTM)
info
$27.65
Technicals
Beta
info
1.13
52-week High
info
$156.66
52-week Low
info
$97.36
50-day moving average
info
$134.87
200-day moving average
info
$127.11
Short ratio
info
2.72
Short %
info
4.26%
Management effectiveness
ROE (TTM)
info
39.51%
ROA (TTM)
info
2.62%
Profit margin
info
36.11%
Gross profit margin
info
$2.97B
Operating margin
info
23.98%
Growth
Quarterly earnings growth (YoY)
info
96.50%
Quarterly revenue growth (YoY)
info
3.50%
Share stats
Outstanding Shares
info
159M
Float
info
158M
Insiders %
info
0.27%
Institutions %
info
107.31%
Analyst Insights & forecasts
info

48% Buy

48% Hold

4% Sell

Based on information from 25 analysts.

Average price target

info
$147.56
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.09
$0.04
125.00%
Q1 • 24Beat
$0.36
$0.90
60.00%
Q2 • 24Beat
$1.14
$0.88
29.55%
Q3 • 24Beat
$0.86
$0.92
6.81%
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$1.08B
$705M
65.28%
Q3 • 24
$1.1B
$187M
16.94%
Q4 • 24
2.22%
73.48%
74.05%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$6.01B
$3.89B
64.67%
Q3 • 24
$6.3B
$3.59B
56.97%
Q4 • 24
4.81%
7.66%
11.90%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$316M
$-41M
$-332M
$284M
Q3 • 24
$364M
$-48M
$-47M
$322M
Q4 • 24
15.19%
17.07%
85.84%
13.38%
QoQ growth
QuarterlyAnnual
Sentiment analysis

-1.5

Neutral

+1.5

-0.10

Last 30 days

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Illumina Inc share?
Collapse

Illumina Inc shares are currently traded for $100.24 per share.

How many shares does Illumina Inc have?
Collapse

Illumina Inc currently has 159M shares.

Does Illumina Inc pay dividends?
Collapse

No, Illumina Inc doesn't pay dividends.

What is Illumina Inc 52 week high?
Collapse

Illumina Inc 52 week high is $156.66.

What is Illumina Inc 52 week low?
Collapse

Illumina Inc 52 week low is $97.36.

What is the 200-day moving average of Illumina Inc?
Collapse

Illumina Inc 200-day moving average is $127.11.

Who is Illumina Inc CEO?
Collapse

The CEO of Illumina Inc is Jacob Thaysen Ph.D..

How many employees Illumina Inc has?
Collapse

Illumina Inc has 10,590 employees.

What is the market cap of Illumina Inc?
Collapse

The market cap of Illumina Inc is $16.1B.

What is the P/E of Illumina Inc?
Collapse

The current P/E of Illumina Inc is null.

What is the EPS of Illumina Inc?
Collapse

The EPS of Illumina Inc is -$7.68.

What is the PEG Ratio of Illumina Inc?
Collapse

The PEG Ration of Illumina Inc is 0.62.

What do analysts say about Illumina Inc?
Collapse

According to the analysts Illumina Inc is considered a buy.